Seguir
Dong Yin
Dong Yin
Afiliación desconocida
Dirección de correo verificada de mail.sysu.edu.cn
Título
Citado por
Citado por
Año
Genomic and molecular characterization of esophageal squamous cell carcinoma
DC Lin, JJ Hao, Y Nagata, L Xu, L Shang, X Meng, Y Sato, Y Okuno, ...
Nature genetics 46 (5), 467-473, 2014
6282014
Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells
NH Thoennissen, GB Iwanski, NB Doan, R Okamoto, P Lin, S Abbassi, ...
Cancer research 69 (14), 5876-5884, 2009
3082009
Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)
D Yin, H Zhou, T Kumagai, G Liu, JM Ong, KL Black, HP Koeffler
Oncogene 24 (3), 344-354, 2005
2782005
Short-and long-term outcomes after laparoscopic and open hepatectomy for hepatocellular carcinoma: a global systematic review and meta-analysis
Z Yin, X Fan, H Ye, D Yin, J Wang
Annals of surgical oncology 20, 1203-1215, 2013
2662013
Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas
D Xie, D Yin, HJ Wang, GT Liu, R Elashoff, K Black, HP Koeffler
Clinical Cancer Research 10 (6), 2072-2081, 2004
2562004
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
T Kumagai, N Wakimoto, D Yin, S Gery, N Kawamata, N Takai, N Komatsu, ...
International journal of cancer 121 (3), 656-665, 2007
2322007
Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and β-catenin-TCF/Lef signaling pathways
D Xie, D Yin, X Tong, J O’Kelly, A Mori, C Miller, K Black, D Gui, JW Said, ...
Cancer research 64 (6), 1987-1996, 2004
2232004
A role for the clock gene per1 in prostate cancer
Q Cao, S Gery, A Dashti, D Yin, Y Zhou, J Gu, HP Koeffler
Cancer research 69 (19), 7619-7625, 2009
2192009
Genomic and epigenomic heterogeneity of hepatocellular carcinoma
DC Lin, A Mayakonda, HQ Dinh, P Huang, L Lin, X Liu, L Ding, J Wang, ...
Cancer research 77 (9), 2255-2265, 2017
1852017
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo
D Yin, JM Ong, J Hu, JC Desmond, N Kawamata, BM Konda, KL Black, ...
Clinical Cancer Research 13 (3), 1045-1052, 2007
1832007
Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo
N Wakimoto, D Yin, J O’Kelly, T Haritunians, B Karlan, J Said, H Xing, ...
Cancer science 99 (9), 1793-1797, 2008
1562008
Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): simultaneous or delayed?
Z Yin, C Liu, Y Chen, Y Bai, C Shang, R Yin, D Yin, J Wang
Hepatology 57 (6), 2346-2357, 2013
1522013
Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through β-catenin-T-cell factor/Lef signaling
YZ Deng, PP Chen, Y Wang, D Yin, HP Koeffler, B Li, XJ Tong, D Xie
Journal of Biological Chemistry 282 (50), 36571-36581, 2007
1512007
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
D Yin, S Ogawa, N Kawamata, A Leiter, M Ham, D Li, NB Doan, JW Said, ...
Oncogene 32 (9), 1155-1163, 2013
1462013
SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells
N Komatsu, N Kawamata, S Takeuchi, D Yin, W Chien, CW Miller, ...
Oncology reports 15 (1), 187-191, 2006
1452006
Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells
S Gery, D Xie, D Yin, H Gabra, C Miller, H Wang, D Scott, WS Yi, ...
Clinical cancer research 11 (20), 7243-7254, 2005
1392005
High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray
D Yin, S Ogawa, N Kawamata, P Tunici, G Finocchiaro, M Eoli, C Ruckert, ...
Molecular Cancer Research 7 (5), 665-677, 2009
1292009
Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme
D Yin, N Wakimoto, H Xing, D Lu, T Huynh, X Wang, KL Black, HP Koeffler
International Journal of Cancer 123 (6), 1364-1375, 2008
1282008
Dlk1 in normal and abnormal hematopoiesis
S Sakajiri, J O'kelly, D Yin, CW Miller, WK Hofmann, K Oshimi, LY Shih, ...
Leukemia 19 (8), 1404-1410, 2005
1232005
DLK1: increased expression in gliomas and associated with oncogenic activities
D Yin, D Xie, S Sakajiri, CW Miller, H Zhu, ML Popoviciu, JW Said, ...
Oncogene 25 (13), 1852-1861, 2006
1202006
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20